- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Norland’s Paris scanner hits market
Bone densitometry firm Norland Medical Systems continues to make progress in rolling out its Paris ultrasound bone measurement system. The company has begun delivery of Paris systems to European and Pacific Rim customers, and is shipping Paris to
Bone densitometry firm Norland Medical Systems continues to make progress in rolling out its Paris ultrasound bone measurement system. The company has begun delivery of Paris systems to European and Pacific Rim customers, and is shipping Paris to physician investigators for testing as part of the Food and Drug Administration's premarket approval process. Norland expects to file its PMA this quarter.
In other company news, Norland has received FDA 510(k) clearance to market a fracture risk assessment feature for its pDEXA x-ray peripheral bone densitometer. Physicians can use the feature to select patients who might benefit from preventive treatment to avoid fractures, as well as to make clinical decisions regarding therapeutic intervention, according to White Plains, NY-based Norland.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
